Literature DB >> 29921477

Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review.

Katerina Pavenski1, Simon Stanworth2, Mark Fung3, Erica M Wood4, Joanne Pink5, Michael F Murphy6, Heather Hume7, Susan Nahirniak8, Kathryn E Webert9, Susano Tanael10, Denise Landry11, Nadine Shehata12.   

Abstract

Many transfusion guidelines are available, but little appraisal of their quality has been undertaken. The quality of guidelines may potentially influence adoption. Our aim was to determine the quality of evidence-based transfusion guidelines (EBG) for red cells and plasma, using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument, and assess duplication and consistency of recommendations. MEDLINE and EMBASE were systematically searched for EBG from 2005 to June 3, 2016. Citations were reviewed for inclusion in duplicate. A guideline was included if it had a specified clinical question, described a systematic search strategy, included critical appraisal of the literature and a description of how recommendations were developed. Four to six physicians used AGREE II to appraise each guideline. Median and scaled scores were calculated, with each item scored on a scale of one to seven, seven representing the highest score. Of 6174 citations, 30 guidelines met inclusion criteria. Twenty six guidelines had recommendations for red cells and 18 included recommendations for plasma use. The median score, the scaled score and the interquartile range of the scaled score were: scope and purpose: median score 5, scaled score 60%, IQR (49-74%); stakeholder involvement 4, 43%, (33-49%); rigor of development 4, 41%, (19-59%); clarity of presentation 5, 69%, (52-81%); applicability 1, 16%, (9-23%); editorial independence 3, 43%, (20-58%). Sixteen guidelines were evaluated to have a scaled domain score of 50% or less. Variations in recommendations were found for the use of hemoglobin triggers for red cell transfusion in patients with acute coronary syndromes and for plasma use for patients with bleeding. Our findings document, limited rigor in guideline development and duplication and inconsistencies in recommendations for the same topic. The process of developing guidelines for red cells and plasma transfusion can be enhanced to improve implementation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AGREE II; Guidelines; Plasma; Quality; Rbc

Year:  2018        PMID: 29921477     DOI: 10.1016/j.tmrv.2018.05.004

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  6 in total

1.  Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis.

Authors:  Derek J B Kleinveld; Derek D G Simons; Charlotte Dekimpe; Shannen J Deconinck; Pieter H Sloos; M Adrie W Maas; Jesper Kers; Joshua Muia; Karim Brohi; Jan Voorberg; Karen Vanhoorelbeke; Markus W Hollmann; Nicole P Juffermans
Journal:  Blood Adv       Date:  2021-09-14

Review 2.  Transfusion thresholds for guiding red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Jane A Dennis; Marialena Trivella; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Dorée; Paul C Hébert
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

3.  Consensus Report on Patient Blood Management in Cardiac Surgery by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Cardiology (TSC), and Society of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care (SCTAIC).

Authors:  Serkan Ertugay; Türkan Kudsioğlu; Taner Şen
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-10-23       Impact factor: 0.332

4.  Guidelines on the intraoperative transfusion of red blood cells: a protocol for systematic review.

Authors:  Laura Baker; Lily Park; Richard Gilbert; Andre Martel; Hilalion Ahn; Alexandra Davies; Daniel I McIsaac; Elianna Saidenberg; Alan Tinmouth; Dean A Fergusson; Guillaume Martel
Journal:  BMJ Open       Date:  2019-06-17       Impact factor: 2.692

5.  The structure of the quality of clinical practice guidelines with the items and overall assessment in AGREE II: a regression analysis.

Authors:  Yosuke Hatakeyama; Kanako Seto; Rebeka Amin; Takefumi Kitazawa; Shigeru Fujita; Kunichika Matsumoto; Tomonori Hasegawa
Journal:  BMC Health Serv Res       Date:  2019-11-04       Impact factor: 2.655

6.  Slowing decline in blood collection and transfusion in the United States - 2017.

Authors:  Jefferson M Jones; Mathew R P Sapiano; Alexandra A Savinkina; Kathryn A Haass; Misha L Baker; Richard A Henry; James J Berger; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2020-02-21       Impact factor: 3.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.